Cancer Research UK Science and Innovation’s Post

Great as always to speak to Executive Director of Research and Innovation at Cancer Research UK, Iain Foulkes, for the latest episode of The Appraisal. We chat about how researchers are rewarded and incentivised, and why this needs to change if the UK is to become a life science superpower. It comes off the back of our freshly launched Manifesto for Cancer Research and Care which sets out the measures and commitments the next government can make to help prevent 20,000 cancer deaths every year by 2040. https://lnkd.in/emi6AkzF

The EORTC-led STRASS/STREXIT 2 Project and LEGATO Project are part of a series of 12 pragmatic clinical trials funded by the Horizon Europe program, aligning with the European Union Mission on Cancer.   The primary objective of these projects is to optimise the diagnosis and treatment of patients with refractory cancers.   ▶️ Watch the video to learn more about the Horizon Europe Cancer Cluster: https://lnkd.in/d7h7paaq Winan van Houdt, Matthias Preusser #STREXIT2_Horizon #LEGATO_Horizon #HorizonEurope #EUCancerMission #PragmaticTrials #CancerResearch #ClinicalTrials 

Catch a glimpse of the future with me as we discuss innovation in cancer treatment, diagnosis and therapy on 1 February! 🩺🗓 Our free online event will explore the intersection of patents, technology and innovation in the fight against cancer. I hope you'll join me to take part in this important and stimulating conversation: https://bit.ly/CancerInno #EPOObservatory #FightCancer #CancerAwareness #InnovationInHealthcare#EPO#EuropeanPatentOffice

Collaboration is a necessity in ensuring a relevant, vibrant, impactful research agenda 🤝 ANZGOG has a diverse, multidisciplinary membership of experts who pool their knowledge, share insights, and combine their strengths to advance gynaecological cancer research. One particular collaboration is between scientists and clinicians, who work together to advance research 'bench to bedside' for gynaecological cancer patients. Watch Professor David Bowtell, a world-leading ovarian cancer researcher and ANZGOG member, talk about the importance of this collaboration below 👇 #AdvancingResearchSavingLives

Congratulations Fiyinfolu Balogun, MD, PhD, Assistant Professor, Memorial Sloan Kettering Cancer Center, on being awarded the 2024 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project grant for his study “Investigating the molecular bases of pancreatic cancer disparities in underserved minority communities and increasing clinical trial recruitment employing linguistic intervention.” 👏The LEAD Project aims to broaden inclusivity by actively recruiting and retaining patients from underrepresented minority groups in pancreatic cancer clinical trials. 💜 #ResearchIsFundamental https://lnkd.in/ev7HcfT3

💥 Congratulations to the five research teams that have been chosen to tackle the most demanding challenges in the field of cancer research! ⚙ As part of #CRUK, we are determined to accelerate cancer discoveries. For 40 years scientists from academic universities and leading cancer centres have deposited their research tools with us. These range from antibodies, cell lines, organoids, small molecules, mouse models, cell culture media, proteins, vectors and other state-of- the-art technologies. ➡️ Click on the link below to learn more about the most recent funding round and get to know the teams. #cancertoolsorg #cancerresearch #lifesciences #cancergrandchallenges

Welcome to our LinkedIn official page. Follow us for the latest updates, insights, and support on all things related to testicular cancer. Our work focuses on the spectrum of issues faced by testicular cancer survivors, ranging from self-examinations to survivorship quality of life. Let's raise awareness, whatever it takes. #testicularcancer #testicularcancerawareness #cancerawareness

Made the trip down to National Cancer Centre Singapore earlier today for an enlightening sharing by Prof. Fan Rong (Yale University) and co-hosted by Singleron APAC! Interesting takeaway - Although Th1 T cells are considered to be the main player for #CAR-T cancer #immunotherapy, the underappreciated Th2 T cells turn out to be indispensable for long-term efficacy and preventing relapse. Today's problems are often multidisciplinary in nature. Solving them will require us to be like the T cells - coming together with our diverse expertise and skillsets to create new solutions. As we deal with the challenges of today, let's remember not just to go at it alone, but also leverage each others talents for a better tomorrow.

״Early is still too late” These words are the most important ones to comprehend when we speak about pancreatic cancer. With survival rates of around 10% one year from the diagnosis there is no doubt that new approaches of early detection needs to be developed. I had the honor to participate in the PANCAID 2nd general assembly meeting that was held in Madrid. During the interesting gathering we continued to discuss and show case our joint collabrative efforts to utilize liquid biopsy and AI driven tools for the early detection of pancreatic cancer. KSM Research & Innovation #healtheverywherenow

🎗️For 15 years, Stand Up To Cancer (#SU2C), observed every second Friday in September, has accelerated innovative cancer research and united people worldwide against cancer. In the battle against cancer, innovative solutions like #Eviti Connect for Oncology are pivotal. It streamlines care for better outcomes, showing that technology and data-driven insights can make a difference. #StandUpToCancer Day unites us in a common cause, offering hope and inspiring action. Learn more about this organization making a big impact ▶️ https://hubs.ly/Q020PJ8N0